MyLeukemiaTeam

How serious is plasma cell leukemia (PCL)?

Plasma cell leukemia is a very serious and aggressive blood cancer that requires immediate treatment. It's considered a more advanced form of multiple myeloma and is quite rare, affecting about 1,200 people annually in the United States.

The prognosis for PCL is challenging Show Full Answer

How serious is plasma cell leukemia (PCL)?

Plasma cell leukemia is a very serious and aggressive blood cancer that requires immediate treatment. It's considered a more advanced form of multiple myeloma and is quite rare, affecting about 1,200 people annually in the United States.

The prognosis for PCL is challenging. Historically, people diagnosed with PCL lived an average of seven months. However, newer treatments have been improving survival rates, and those receiving stem cell transplants may live an average of two to three years.

Several factors can affect outcomes:

Better prognosis:
* Primary PCL (occurring without previous multiple myeloma)
* Younger age (under 60 years old)

Poorer prognosis:
* Secondary PCL (developing from multiple myeloma)
* Age 60 or older
* Low platelet count (less than 100 billion/L)
* High plasma cell count in blood (at least 20 billion/L)
* Certain genetic changes like chromosome abnormalities

Because PCL progresses quickly, starting treatment as soon as possible after diagnosis is critical for the best possible outcome.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Plasma Cell Leukemia: An Overview